MASHINIi

Heartbeam, Inc..

BEAT.US | Research and experimental development on natural sciences and engineering

Heartbeam, Inc. is a development stage company focused on transforming cardiac care through the development of a 3D-vector electrocardiogram (3D-VCG) platform technology to detect heart attacks early, especially in out-of-hospital settings. Their primary product under development is the Heartbeam AI...Show More

Ethical Profile

Mixed.

Heartbeam, Inc. is advancing cardiac care with its AIMIGo system, a credit card-sized device for early heart attack detection. Clinical data presented at AHA 2024 showed 94% sensitivity and 100% specificity for arrhythmia diagnosis, while its AI demonstrated 97.3% sensitivity in detecting atrial flutter. The system has received FDA 510(k) clearance, potentially improving diagnostic access. However, reports suggest limited public information regarding the technology's price accessibility. Furthermore, comprehensive data on the company's practices in areas such as fair pay, ethical sourcing, environmental impact, and data security is largely unavailable, making a full ethical assessment challenging.

Value Scores

Better Health for All50
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

50

The company's core product, a 3D-VCG platform, demonstrated 94% sensitivity and 100% specificity for arrhythmia diagnosis in a pivotal trial, with a potential to reduce misdiagnosis by over 30%.

1
HeartBeam AI also showed 97.3% sensitivity in detecting atrial flutter, outperforming an expert panel's 69.4% sensitivity using single-lead ECGs and improving 12-lead ECGs by 6%.
2
As a pre-revenue company founded in 2015,
3
all its activities are focused on developing these health-positive diagnostic technologies, meaning it has zero revenue from harmful products since its inception. The company is heavily involved in research, development, and clinical trials to gain regulatory approvals for its technology, including acquiring patents and raising $10 million in equity,
4
indicating that 100% of its R&D and capital allocation is aimed at improving health outcomes. The device's ability to enable earlier diagnosis implies a focus on preventative health measures. The company conducts clinical trials, such as the VALID-ECG trial with 198 patients across 5 clinical sites,
5
demonstrating a commitment to ethical research practices.

Fair Money & Economic Opportunity

0

No evidence available to assess Heartbeam, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No specific, concrete data points were found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. Articles and explicitly state that key metrics such as living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, insecure contract share, and health insurance coverage are missing.

1
Furthermore, for labor violation incidents, the articles note a 'lack of detailed information' or that 'no regulatory actions, violations, fines, or compliance issues are mentioned,' which does not constitute evidence of zero incidents but rather an absence of data.
2

Fair Trade & Ethical Sourcing

0

No specific, quantitative data relevant to Fair Trade & Ethical Sourcing KPIs was found in the provided articles. The articles either failed to load due to throttling issues or contained general corporate conduct policies without addressing supplier relationships, certifications, audits, or other specific sourcing practices.

1

Honest & Fair Business

0

No evidence available to assess Heartbeam, Inc. on Honest & Fair Business.

Kind to Animals

0

No specific, concrete evidence was found in the provided articles to score Heartbeam, Inc. against any of the 'Kind to Animals' KPIs. states that Heartbeam, Inc. does not engage in animal exploitation, but this general statement lacks the specific quantitative or qualitative detail required by the rubric for scoring.

1
discusses FDA policies and initiatives regarding animal testing reduction, but these are actions and policies of the regulator, not specific practices, policies, or volumes attributable to Heartbeam, Inc.
2

No War, No Weapons

0

No evidence was found in the provided articles to assess Heartbeam, Inc. against any of the 'No War, No Weapons' KPIs. The single article explicitly states it does not contain data relevant to BEAT.US or the requested categories.

1

Planet-Friendly Business

0

The provided articles focus on Heartbeam, Inc.'s medical technology, market position, and financial results, including FDA clearances, clinical trial outcomes, and patent information. None of the articles contain specific, concrete data points or information related to environmental performance, such as carbon emissions, renewable energy use, waste management, water consumption, or climate-related policies and initiatives. Therefore, no KPIs under the 'Planet-Friendly Business' value can be scored based on the evidence provided.

Respect for Cultures & Communities

0

No evidence available to assess Heartbeam, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

The provided articles do not contain specific, concrete data points for any of the Key Performance Indicators (KPIs) under the 'Safe & Smart Tech' ethical value for Heartbeam, Inc. (BEAT.US). discusses general cybersecurity trends in the healthcare sector but does not provide company-specific information.

1
focuses solely on the company's financial health.
2
Therefore, no assessment can be made against the defined KPIs.

Zero Waste & Sustainable Products

0

No specific, concrete data points were found in the provided articles for Heartbeam, Inc. (BEAT.US) regarding any of the Zero Waste & Sustainable Products KPIs.

1
The articles either explicitly state they do not contain relevant data for BEAT.US, discuss general industry trends, or focus on the company's financial and product development updates without mentioning environmental sustainability metrics.
2

Own Heartbeam, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.